I’m trying to figure out why, when, and how we started calling people patients. Especially since one of them reminded me today that they’re often not very patient at all.

0 13

squamous with pressing need for better outcomes. Combination of afatinib and pembrolizumab discussed by - unfortunately not well tolerated. 40% with G3 AEs.

3 15

Interesting data from with pembrolizumab in locally advanced after chemoradiation. Current standard here remains durvalumab but this appears consistent with what we would expect.

8 21

New Review by Wade Iams, Jason Porter & Leora Horn now live online: 'Immunotherapeutic approaches for small-cell lung cancer': https://t.co/M61qCmE4eY

23 42

Why can’t we just focus on smoking cessation to prevent lung cancer? Because it can’t prevent lung cancer; it can only reduce risk. These are different phenomena.

6 28

11 DAYS UNTIL What’s the future for e-cigarettes? , BTOG Steering Committee member, will tell us at the BTOG Medicine & Symposium https://t.co/Sulro3MsXl

3 7

2019 memonries: He thought he’d actually win this debate.

0 15

UGHHHH NO SE COM SELLAMA EL DE MORADO PERO QUE MAL CAE LCSM QUE SE CALLEEEEE

1 14